Eur. Urol. 2013 Mar 26
Personalizing the management of men with intermediate-risk prostate cancer.
Related Questions
New comment by Radiation Oncologist at Jacob E Locke MD PA ( February 27, 2023)
A favorable intermediate patient with otherwise intermediate risk (no nodule, PSA velocity 2 years and under 10, Gleason 3+4) and then a Decipher comes in at HI risk (0.76).
...